Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

ACRS Insider Trading (Aclaris Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,040,685.45

Aclaris Therapeutics Insider Trading History Chart

Aclaris Therapeutics Share Price & Price History

^$13.83

▼ -0.13 (-0.93%)

As of 07/1/2022 06:43 PM ET

Days: 30 | 90 | 365

Better Options For Trading!

From Tradewins | Ad

I know–you’ve heard options trading is tough, but is it really tougher than the market is right now?

NO! “Options Trading Made Easy” by pro-trader Chuck Hughes gives traders the best options in an unpredictable market…

Get your copy now!

>>>

Aclaris Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/17/2022	Andrew N. Schiff	Director	Sell	19,565	$15.14	$296,214.10
4/25/2022	Neal Walker	CEO	Sell	20,000	$15.18	$303,600.00	1,245,763
4/21/2022	Neal Walker	CEO	Sell	25,000	$15.24	$381,000.00	1,290,763
4/18/2022	Joseph Monahan	Insider	Sell	30,000	$16.28	$488,400.00	106,386
3/11/2022	Neal Walker	CEO	Sell	56,303	$15.91	$895,780.73
3/10/2022	Frank Ruffo	CFO	Sell	12,823	$15.55	$199,397.65
3/10/2022	Joseph Monahan	Insider	Sell	27,165	$15.71	$426,762.15
2/9/2022	Joseph Monahan	Insider	Sell	383	$12.68	$4,856.44
7/13/2021	David N. Gordon	Insider	Sell	2,631	$16.98	$44,674.38	147,447
6/3/2021	Kamil Ali-Jackson	Insider	Sell	9,492	$21.96	$208,444.32	122,196
6/2/2021	Neal Walker	CEO	Sell	33,260	$21.64	$719,746.40	1,265,442
6/1/2021	David N. Gordon	Insider	Sell	14,000	$23.01	$322,140.00	195,992
5/7/2021	Kamil Ali-Jackson	Insider	Sell	5,416	$23.52	$127,384.32	158,618
5/5/2021	Kamil Ali-Jackson	Insider	Sell	15,000	$23.98	$359,700.00	158,618
5/3/2021	Kamil Ali-Jackson	Insider	Sell	15,000	$24.59	$368,850.00	158,618
4/26/2021	Frank Ruffo	CFO	Sell	27,339	$25.80	$705,346.20	209,059
4/22/2021	Frank Ruffo	CFO	Sell	30,000	$26.84	$805,200.00	209,059

This Has Won 99.1% Of Trades Over 3 Years

From Investing Daily | Ad

Video reveals the most powerful trade you’ve NEVER heard of. Released every Tuesday, it could DOUBLE your money by Friday.

In past 3 years, it’s won 321 out of 324 of these trades, with the majority making 100%+ every 3-10 days.

See how a simple 10-minute trade on Tue could double your money by Fri.

Watch Video Now For Full Details.

>>>

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

97.79% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aclaris Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/30/2022	Amalgamated Bank	8,306	$0.14M	0.0%	N/A	0.012%
6/7/2022	Teachers Retirement System of The State of Kentucky	66,814	$1.15M	0.0%	+7.2%	0.100%
6/7/2022	Bank of America Corp DE	31,314	$0.54M	0.0%	-48.4%	0.047%
6/2/2022	Verition Fund Management LLC	255,478	$4.40M	0.1%	+43.3%	0.384%
5/18/2022	BNP Paribas Arbitrage SA	4,426	$76K	0.0%	-59.2%	0.007%
5/17/2022	RA Capital Management L.P.	1,817,808	$31.34M	0.7%	N/A	2.730%
5/17/2022	Royal Bank of Canada	3,137	$54K	0.0%	-70.8%	0.005%
5/17/2022	Rock Springs Capital Management LP	3,865,034	$66.63M	1.7%	+0.1%	5.805%
5/17/2022	Great Point Partners LLC	942,445	$16.25M	3.9%	+17.8%	1.416%
5/16/2022	California State Teachers Retirement System	60,986	$1.05M	0.0%	-8.2%	0.100%
5/16/2022	Goldman Sachs Group Inc.	258,459	$4.46M	0.0%	+16.8%	0.422%
5/16/2022	Wellington Management Group LLP	5,730,253	$98.79M	0.0%	+3.4%	9.352%
5/16/2022	State Street Corp	1,083,390	$18.68M	0.0%	+3.4%	1.768%
5/16/2022	Frazier Life Sciences Management L.P.	408,329	$7.04M	0.6%	N/A	0.666%
5/16/2022	Ghost Tree Capital LLC	125,000	$2.16M	0.5%	-61.5%	0.204%
5/16/2022	UBS Group AG	1,702	$29K	0.0%	-96.3%	0.003%
5/13/2022	Silverarc Capital Management LLC	275,333	$4.75M	2.0%	-3.8%	0.449%
5/13/2022	Renaissance Technologies LLC	1,457,578	$25.13M	0.0%	-13.1%	2.379%
5/13/2022	Northern Trust Corp	470,166	$8.11M	0.0%	-4.0%	0.767%
5/13/2022	Verition Fund Management LLC	255,478	$4.40M	0.1%	+43.3%	0.417%
5/13/2022	Charles Schwab Investment Management Inc.	133,068	$2.30M	0.0%	+3.2%	0.217%
5/13/2022	Affinity Asset Advisors LLC	100,000	$1.72M	0.3%	-75.0%	0.163%
5/13/2022	American International Group Inc.	25,323	$0.44M	0.0%	-6.6%	0.041%
5/13/2022	Parkman Healthcare Partners LLC	668,098	$11.52M	3.4%	-34.9%	1.090%
5/13/2022	Vanguard Group Inc.	2,728,820	$47.05M	0.0%	+0.4%	4.453%
5/13/2022	Allianz Asset Management GmbH	81,965	$1.41M	0.0%	+44.2%	0.134%
5/12/2022	Integral Health Asset Management LLC	238,000	$4.10M	1.1%	+19.0%	0.388%
5/12/2022	BlackRock Inc.	3,987,107	$68.74M	0.0%	-2.2%	6.507%
5/12/2022	Rhumbline Advisers	55,194	$0.95M	0.0%	+18.1%	0.090%
5/12/2022	Metropolitan Life Insurance Co NY	2,996	$52K	0.0%	-76.4%	0.005%
5/12/2022	MetLife Investment Management LLC	26,282	$0.45M	0.0%	+58.5%	0.043%
5/12/2022	Citigroup Inc.	8,392	$0.15M	0.0%	-52.3%	0.014%
5/12/2022	HighTower Advisors LLC	63,299	$1.09M	0.0%	-6.7%	0.103%
5/11/2022	JPMorgan Chase & Co.	44,650	$0.77M	0.0%	+20.0%	0.073%
5/10/2022	ProShare Advisors LLC	15,905	$0.27M	0.0%	-19.5%	0.026%
5/9/2022	Principal Financial Group Inc.	32,253	$0.56M	0.0%	-29.0%	0.053%
5/9/2022	Swiss National Bank	108,500	$1.87M	0.0%	+7.4%	0.177%
5/5/2022	New York State Common Retirement Fund	38,955	$0.67M	0.0%	+24.3%	0.064%
4/28/2022	DekaBank Deutsche Girozentrale	22,000	$0.39M	0.0%	+10.0%	0.036%
4/25/2022	Assenagon Asset Management S.A.	507,435	$8.75M	0.0%	N/A	0.828%
2/25/2022	AlphaCentric Advisors LLC	68,000	$0.99M	0.3%	N/A	0.111%
2/18/2022	TCG Crossover Management LLC	1,082,213	$15.74M	7.4%	N/A	1.767%
2/16/2022	Ghost Tree Capital LLC	325,000	$4.73M	1.7%	+18.2%	0.531%
2/15/2022	Schonfeld Strategic Advisors LLC	490,460	$7.13M	0.1%	-4.4%	0.801%
2/15/2022	Sender Co & Partners Inc.	30,132	$0.44M	0.2%	N/A	0.049%
2/15/2022	Laurion Capital Management LP	1,115,075	$16.21M	0.2%	+126.4%	1.821%
2/15/2022	Commodore Capital LP	2,672,346	$38.86M	9.0%	+22.0%	4.365%
2/15/2022	Darwin Global Management Ltd.	216,143	$3.14M	0.5%	+35.6%	0.353%
2/15/2022	Adage Capital Partners GP L.L.C.	899,997	$13.09M	0.0%	-16.3%	1.470%
2/14/2022	Point72 Hong Kong Ltd	1,784	$26K	0.0%	N/A	0.003%
2/14/2022	Point72 Asset Management L.P.	642,900	$9.35M	0.0%	+64.3%	1.050%
2/14/2022	Blair William & Co. IL	12,800	$0.19M	0.0%	+27.4%	0.021%
2/14/2022	Affinity Asset Advisors LLC	400,000	$5.82M	2.1%	+14.3%	0.653%
2/11/2022	Renaissance Technologies LLC	1,676,878	$24.38M	0.0%	-17.0%	2.739%
2/11/2022	Ensign Peak Advisors Inc	10,970	$0.16M	0.0%	N/A	0.018%
2/10/2022	OLD Mission Capital LLC	15,663	$0.23M	0.0%	N/A	0.026%
2/9/2022	Principal Financial Group Inc.	45,405	$0.66M	0.0%	-14.3%	0.074%
2/9/2022	BNP Paribas Arbitrage SA	10,852	$0.16M	0.0%	+20.2%	0.018%
2/9/2022	Fox Run Management L.L.C.	19,368	$0.28M	0.2%	N/A	0.032%
2/8/2022	Swiss National Bank	101,000	$1.47M	0.0%	+3.9%	0.165%
2/8/2022	Handelsbanken Fonder AB	13,800	$0.20M	0.0%	N/A	0.023%
2/8/2022	ProShare Advisors LLC	19,760	$0.29M	0.0%	N/A	0.032%
2/8/2022	Northern Trust Corp	489,796	$7.12M	0.0%	-2.4%	0.800%
2/7/2022	Victory Capital Management Inc.	22,650	$0.33M	0.0%	-33.6%	0.037%
2/7/2022	SG Americas Securities LLC	13,679	$0.20M	0.0%	-34.9%	0.022%
2/2/2022	Integral Health Asset Management LLC	200,000	$2.91M	0.8%	+8.1%	0.327%
2/2/2022	DekaBank Deutsche Girozentrale	20,000	$0.29M	0.0%	N/A	0.033%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	7,501	$0.11M	0.0%	+133.6%	0.012%
1/28/2022	Allspring Global Investments Holdings LLC	8,559	$0.12M	0.0%	N/A	0.014%
1/28/2022	Hamilton Lane Advisors LLC	97,550	$1.42M	0.2%	N/A	0.159%
1/19/2022	Asymmetry Capital Management L.P.	198,493	$2.89M	1.5%	-17.9%	0.324%
12/14/2021	UBS Asset Management Americas Inc.	36,466	$0.66M	0.0%	+16.6%	0.060%
12/3/2021	Perceptive Advisors LLC	781,236	$14.06M	0.2%	-8.1%	1.276%
12/1/2021	Balyasny Asset Management LLC	161,843	$2.91M	0.0%	+4.8%	0.264%
11/16/2021	Schonfeld Strategic Advisors LLC	512,875	$9.23M	0.1%	+101.6%	0.838%
11/16/2021	Squarepoint Ops LLC	15,834	$0.29M	0.0%	N/A	0.026%
11/16/2021	Two Sigma Investments LP	109,828	$1.98M	0.0%	-70.7%	0.179%
11/16/2021	Telemetry Investments L.L.C.	31,500	$0.57M	0.8%	-7.4%	0.051%
11/16/2021	Wellington Management Group LLP	5,420,453	$97.57M	0.0%	+15.4%	8.853%
11/16/2021	Laurion Capital Management LP	492,500	$8.87M	0.0%	-7.7%	0.804%
11/16/2021	BVF Inc. IL	1,373,044	$24.72M	1.0%	+37.3%	2.243%
11/16/2021	Commodore Capital LP	2,190,291	$39.43M	10.4%	+31.2%	3.577%
11/15/2021	Point72 Asset Management L.P.	391,300	$7.04M	0.0%	-18.2%	0.639%
11/15/2021	Cubist Systematic Strategies LLC	19,000	$0.34M	0.0%	-64.3%	0.031%
11/15/2021	California State Teachers Retirement System	63,821	$1.15M	0.0%	+6.6%	0.104%
11/15/2021	Tudor Investment Corp Et Al	10,539	$0.19M	0.0%	N/A	0.017%
11/15/2021	Rock Springs Capital Management LP	3,803,232	$68.46M	1.4%	+1.1%	6.212%
11/15/2021	Marshall Wace LLP	13,619	$0.25M	0.0%	N/A	0.022%
11/15/2021	Great Point Partners LLC	500,000	$9M	2.1%	N/A	0.817%
11/15/2021	Atom Investors LP	25,197	$0.45M	0.0%	-86.2%	0.041%
11/15/2021	Balyasny Asset Management LLC	161,843	$2.91M	0.0%	+4.8%	0.264%
11/15/2021	Invesco Ltd.	438,802	$7.90M	0.0%	+2,103.3%	0.717%
11/15/2021	HighVista Strategies LLC	93,000	$1.68M	1.1%	+134.4%	0.152%
11/15/2021	Voya Investment Management LLC	19,743	$0.36M	0.0%	+15.2%	0.032%
11/15/2021	Jetstream Capital LLC	140,000	$2.52M	2.4%	N/A	0.229%
11/15/2021	Franklin Resources Inc.	36,600	$0.66M	0.0%	N/A	0.060%
11/15/2021	HighTower Advisors LLC	68,278	$1.23M	0.0%	+5.9%	0.112%
11/12/2021	Affinity Asset Advisors LLC	350,000	$6.30M	1.6%	+27.3%	0.572%
11/12/2021	Renaissance Technologies LLC	2,020,878	$36.38M	0.0%	-16.9%	3.301%
11/12/2021	Parkman Healthcare Partners LLC	1,306,460	$23.52M	5.9%	-13.0%	2.134%

Data available starting January 2016

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Today's Range

Now: $13.83

$13.60

$14.00

50 Day Range

MA: $13.39

$10.16

$15.99

52 Week Range

Now: $13.83

$9.26

$19.97

Volume

214,915 shs

Average Volume

481,775 shs

Market Capitalization

$920.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.67

Who are the company insiders with the largest holdings of Aclaris Therapeutics?: Aclaris Therapeutics' top insider shareholders include:
Neal Walker (CEO)
Frank Ruffo (CFO)
David N Gordon (Insider)
Kamil Ali-Jackson (Insider)
Joseph Monahan (Insider)
Andrew N Schiff (Director)
Learn More about top insider investors at Aclaris Therapeutics.

This Options Expert is Giving Everything Away!